As science
continues to advance rapidly, more and more discoveries are being
made about the human body. Though we may think of the future as
involving many technological advances (and no doubt it will), there
are many biological technologies in store for us as well. One such
development that is currently being explored by DARPA involves
turning the human body into a bio-factory to generate antibodies for
use in vaccine production. The current process for making a vaccine
is 9 months, but if DARPA's research proves successful, the human
body could produce antibodies in much less time and with much more
effectiveness. Consider that the 2009 flu vaccine protected only 1.6
percent of the population—in all other cases, it failed to immunize
the patient against the virus. However, with a single shot into a
person's muscle cells, a genetic antibody recipe could be introduced
that would cause RNA to convey these instructions and produce many
copies of the necessary antibodies, which are then harvested for use
in other patients. If the human body is utilized as a bio-factory to
produce antibodies, we might see more effective vaccines produced in
much less time. This study is somewhat predicated upon the success
seen with the antibodies produced by Americans who survived Ebola
infection.
No comments:
Post a Comment